Retour
Fourchette du Jour
9,13 €
9,52 €
Fourchette 52 Semaines
3,30 €
12,41 €
Volume
918 144
Moyenne 50J / 200J
9,83 €
/
8,38 €
Clôture Précédente
9,51 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -6,5 | 0,3 |
| P/B | 2,6 | 2,9 |
| ROE % | -35,7 | 3,7 |
| Net Margin % | -391,0 | 3,8 |
| Rev Growth 5Y % | 8,6 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
21,00 €
+128.3%
Low: 17,00 €
High: 25,00 €
BPA Prévisionnel
-1,54 €
CA Est.
38 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-0,26 €
-0,54 € – -0,01 €
|
380 M | 1 |
| FY2029 |
-0,97 €
-2,02 € – -0,04 €
|
200 M | 1 |
| FY2028 |
-1,40 €
-1,54 € – -1,23 €
|
160 M | 3 |
Points Clés
Revenue grew 8,55% annually over 5 years — modest growth
Earnings declined -1339,94% over the past year
Debt/Equity of 0,03 — conservative balance sheet
Negative free cash flow of -175,95M
PEG of 0,00 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 77,58%
Croissance
Revenue Growth (5Y)
8,55%
Revenue (1Y)-69,03%
Earnings (1Y)-1339,94%
FCF Growth (3Y)N/A
Qualité
Return on Equity
-35,65%
ROIC-26,93%
Net Margin-390,95%
Op. Margin-371,65%
Sécurité
Debt / Equity
0,03
Current Ratio11,72
Interest Coverage-197,41
Valorisation
P/E Ratio
-6,54
P/B Ratio2,55
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -69,03% | Revenue Growth (3Y) | -5,46% |
| Earnings Growth (1Y) | -1339,94% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 8,55% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 48,27M | Net Income (TTM) | -188,69M |
| ROE | -35,65% | ROA | -33,57% |
| Gross Margin | 100,00% | Operating Margin | -371,65% |
| Net Margin | -390,95% | Free Cash Flow (TTM) | -175,95M |
| ROIC | -26,93% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,03 | Current Ratio | 11,72 |
| Interest Coverage | -197,41 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -6,54 | P/B Ratio | 2,55 |
| P/S Ratio | 25,55 | PEG Ratio | 0,00 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,23B | Enterprise Value | 903,25M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 48,27M | 155,84M | 54,00M | 172,83M | 34,76M |
| Net Income | -188,69M | 15,22M | -96,99M | 37,51M | -95,06M |
| EPS (Diluted) | -1,54 | 0,14 | -1,20 | 0,54 | -1,51 |
| Gross Profit | 48,27M | 155,84M | -64,67M | 66,05M | -52,81M |
| Operating Income | -179,38M | -38,62M | -101,73M | 29,95M | -86,29M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 562,10M | 696,15M | 509,97M | 407,82M | 174,65M |
| Total Liabilities | 78,20M | 121,30M | 284,88M | 194,66M | 150,58M |
| Shareholders' Equity | 483,89M | 574,84M | 225,08M | 213,16M | 24,06M |
| Total Debt | 15,63M | 16,20M | 15,40M | 14,56M | 9,85M |
| Cash & Equivalents | 345,77M | 236,75M | 218,47M | 148,52M | 132,99M |
| Current Assets | 503,79M | 629,56M | 449,37M | 377,15M | 152,21M |
| Current Liabilities | 42,99M | 67,99M | 156,55M | 106,45M | 95,15M |